WHO Immunization Implementation Guide
1.0.0 - release

This page is part of the Immunizations (v1.0.0: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

PlanDefinition: IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening

Official URL: http://smart.who.int/immunizations/PlanDefinition/IMMZD2DTDengue3DosesWithoutPreVaccinationScreening Version: 1.0.0
Draft as of 2026-10-02 Computable Name: IMMZD2DTDengue3DosesWithoutPreVaccinationScreening

IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening CYD-TDV (Dengvaxia), 3-dose schedule without pre-vaccination screening [when pre-vaccination screening is not feasible and in areas with recent documentation of seroprevalence rates of at least 80% by age 9 years]

Id: IMMZD2DTDengue3DosesWithoutPreVaccinationScreening
Url: IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening
Version: 1.0.0
Title: IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening
Status: draft
Type:

system: http://terminology.hl7.org/CodeSystem/plan-definition-type

code: eca-rule

Date: 2026-10-02 09:40:20+0000
Publisher: WHO
Description:

IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening CYD-TDV (Dengvaxia), 3-dose schedule without pre-vaccination screening [when pre-vaccination screening is not feasible and in areas with recent documentation of seroprevalence rates of at least 80% by age 9 years]
Knowledge Capability: computable
Related Artifacts:

References

  • ​

    WHO recommendations for routine immunization - summary tables (January 2025)
Libraries:
IMMZD2DTDengue3DosesWithoutPreVaccinationScreeningLogic
Actions:
Determine if the client is due for Dengue.: Determine if the client is due for Dengue vaccine according to the national immunization protocol. CYD-TDV (Dengvaxia), 3-dose schedule without pre-vaccination screening [when pre-vaccination screening is not feasible and in areas with recent documentation of seroprevalence rates of at least 80% by age 9 years]
If: Applicability: Client is due for dengue vaccination (Client is due for dengue vaccination)
Then: Definition: IMMZD2DTMR
Dynamic Values:
status: ('draft')
intent: ('proposal')
medication: (Concept { codes: { Code { system: 'http://smart.who.int/immunizations/CodeSystem/IMMZ.Z', code: 'DE25', display: 'Dengue vaccines' } }, display: 'Dengue vaccines' })
Check for Guidance for the patient regarding IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening.: Show Guidance for the patient regarding IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening.
If: Applicability: Has Guidance (Has Guidance)
Then: Definition: IMMZ.D2.DT.CR
Dynamic Values:
status: ('active')
payload.contentString: (Guidance)
category.coding: (Code { system: 'http://terminology.hl7.org/CodeSystem/communication-category', code: 'alert' })
priority: (Code { system: 'http://hl7.org/fhir/request-priority', code: 'routine' })